SCHEMBL736970

SCHEMBL736970

O=C(O)CC[Si](O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29517940 0.97 LMNA (0.47)
SCHEMBL29518017 0.97 LMNA (0.47)
SCHEMBL29517793 0.97 LMNA (0.47)
SCHEMBL2993922 0.97 LMNA (0.47)
SCHEMBL29517807 0.97 LMNA (0.47)
SCHEMBL29517882 0.97 LMNA (0.47)
SCHEMBL524404 0.97 LMNA (0.47)
SCHEMBL29518480 0.97 LMNA (0.47)
SCHEMBL22231674 0.97 LMNA (0.47)
SCHEMBL29517792 0.97 LMNA (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 606 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688987-A1 POLISHING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM Electronic Materials U.S.A, Inc. (US) 2026-02-11 EP claimed
EP-4689041-A1 CLEANING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM Electronic Materials U.S.A, Inc. (US) 2026-02-11 EP claimed
EP-4676583-A2 SURFACE MODIFICATION OF MEDICAL DEVICES Abiomed, Inc. (US) 2026-01-14 EP claimed
US-20250277134-A1 SILANE MODIFICATION OF CERIA NANOPARTICLES IN COLLOIDALLY STABLE SOLUTIONS CMC MATERIALS LLC 2025-09-04 US claimed
US-12391819-B2 Fluoropolymer-based hybrid organic/inorganic composites SYENSQO SA (BE) 2025-08-19 US claimed
EP-3724939-B1 FLUOROPOLYMER MEMBRANE FOR ELECTROCHEMICAL DEVICES SYENSQO SA (BE) 2025-08-13 EP claimed
WO-2025151713-A1 PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS Arkea Bio Corp. (US) 2025-07-17 WO claimed
WO-2025151711-A1 NUCLEIC ACID VACCINES TARGETING METHANOGENS Arkea Bio Corp. (US) 2025-07-17 WO claimed
US-20250222082-A1 PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS ARKEA BIO CORP (US) 2025-07-10 US claimed
WO-2025128700-A1 CELL-BASED VACCINES Arkea Bio Corp. (US) 2025-06-19 WO claimed
WO-2010076745-A1 SURFACE-MODIFYING AGENTS FOR WETTABILITY MODIFICATION SCHLUMBERGER CANADA LIMITED (CA) 2010-07-08 WO claimed
US-20100163234-A1 Surface-Modifying Agents for Wettability Modification SCHLUMBERGER TECHNOLOGY CORPORATION 2010-07-01 US claimed
WO-2010070600-A1 SURFACE MODIFICATION FOR CROSS-LINKING OR BREAKING INTERACTIONS WITH INJECTED FLUID SCHLUMBERGER CANADA LIMITED (CA) 2010-06-24 WO claimed
US-20100147515-A1 SURFACE MODIFICATION FOR CROSS-LINKING OR BREAKING INTERACTIONS WITH INJECTED FLUID SCHLUMBERGER TECHNOLOGY CORPORATION 2010-06-17 US claimed
US-6727309-B1 FILM-FORMING, EMULSION-BASED POLYMER THAT REVERSIBLE CROSSLINKS AND SURFCE TREATED PARTICLE DISPERSED; WEAR RESISTANCE, STORAGE STABILITY 3M INNOVATIVE PROPERTIES COMPANY 2004-04-27 US claimed
WO-2004033575-A1 FLOOR FINISH COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-04-22 WO claimed
US-20040068035-A1 Surface modified inorganic particles providing enhanced shelf stability and film performance 3M INNOVATIVE PROPERTIES COMPANY 2004-04-08 US claimed
US-20030191205-A1 MOLECULARLY-IMPRINTED MATERIAL MADE BY TEMPLATE-DIRECTED SYNTHESIS MARKOWITZ MICHAEL A (US) 2003-10-09 US claimed
US-20030139483-A1 Molecularly-imprinted material made by template-directed synthesis NAVY, SECRETARY OF THE, THE UNITED STATES OF AMERICA AS, REPRESENTED BY THE 2003-07-24 US claimed
US-20020065334-A1 Molecularly-imprinted material made by template-directed synthesis UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE 2002-05-30 US claimed